Clinical Trial Update: Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a Candida therapeutic vaccine to reduce recurrence in patients with squamous cell carcinoma of the head and neck; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Candida Therapeutic Vaccine

Snippet

Sponsor: University of Arkansas | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: RECRUITING